The invention relates to compositions and methods for modulating the expression of the MLL-AF4 fusion gene, and more particularly to the downregulation of MLL-AF4 by chemically modified oligonucleotides.

 
Web www.patentalert.com

< Isolation and characterization of the precursor virus of human SARS virus: SARS-associated corona virus-like virus

> Protocols for making hepatocytes from embryonic stem cells
~ 00427